Skip to Main Navigation

GABON COVID-19 Strategic Preparedness and Response Project (SPRP)

Abstract*

The Project is organized in three components responding directly to the response Plan: 1) component 1- Emergency COVID-19 Response focuses on case detection, confirmation, contact Tracing, recording, reporting as well as health system strengthening. It also will support Gabon’s response by financing the procurement of medical ambulances with the necessary equipment to provide safe care for COVID19 patients; 2) Supporting National and Sub-national...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

The Project Development Objective (PDO) is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Gabon.

Key Details

Project Details

  • P173927

  • Closed

  • Andre Carletto

  • Republic of Gabon

  • Gabon

  • May 6, 2020

  • (as of board presentation)

    May 15, 2020

  • May 27, 2020

  • US$ 21.00 million

  • Commission nationale des travaux d'intérêt public pour la promotion de l'entrepreneuriat et de l'emp

  • Western and Central Africa

  • 2020

  • US$ 21.00 million

  • N/A

  • March 27, 2024

  • June 30, 2024

  • No

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
International Bank for Reconstruction and Development 21.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 21.00
IDA Commitment N/A
IBRD + IDA Commitment 21.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 21.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
May 24, 2023 IBRD-91240 Int Charges 3,870.46
May 24, 2023 IBRD-91240 Int Charges 32.73
Nov 15, 2022 IBRD-91240 Loan Disb -2,252.91
Nov 15, 2022 IBRD-91240 Loan Disb 2,252.91
Nov 15, 2022 IBRD-91240 Int Charges 1,086.64
Nov 15, 2022 IBRD-91240 Int Charges 3,748.07
Nov 15, 2022 IBRD-91240 Int Charges 110.33
Nov 15, 2022 IBRD-91240 Int Charges 1.21
Nov 15, 2022 IBRD-91240 Int Charges 10,456.56
Nov 15, 2022 IBRD-91240 Int Charges 927.21
Sep 9, 2022 IBRD-91240 Loan Disb 2,179.77
Dec 16, 2021 IBRD-91240 Int Charges 445.36
Dec 16, 2021 IBRD-91240 Int Charges 11,344.35
Dec 16, 2021 IBRD-91240 Int Charges 1,002.53
May 15, 2022 IBRD-91240 Int Charges 925.07
May 15, 2022 IBRD-91240 Loan Disb -387,508.88
May 15, 2022 IBRD-91240 Loan Disb 387,508.88
May 15, 2022 IBRD-91240 Int Charges 1,084.12
Dec 3, 2021 IBRD-91240 Loan Disb 421,846.75
May 15, 2022 IBRD-91240 Int Charges 157.08
May 15, 2022 IBRD-91240 Int Charges 3.12
May 15, 2022 IBRD-91240 Int Charges 10,432.46
Nov 15, 2021 IBRD-91240 Loan Disb -373,463.78
Nov 15, 2021 IBRD-91240 Loan Disb 373,463.78
Aug 19, 2021 IBRD-91240 Loan Disb 23,386.00
Jul 27, 2021 IBRD-91240 Loan Disb 360,909.34
Mar 9, 2021 IBRD-91240 Loan Disb 407,725.53
Dec 10, 2020 IBRD-91240 Int Charges 10,049.74
May 15, 2021 IBRD-91240 Loan Disb -414,935.38
May 15, 2021 IBRD-91240 Loan Disb 414,935.38
May 18, 2021 IBRD-91240 Int Charges 761.99
May 18, 2021 IBRD-91240 Int Charges 12,260.25
Nov 15, 2020 IBRD-91240 Loan Disb -8,477,569.00
Nov 15, 2020 IBRD-91240 Loan Disb 8,477,569.00
Jun 19, 2020 IBRD-91240 Loan Disb 6,225,051.00
May 27, 2020 IBRD-91240 Loan Disb 22,860.28
May 27, 2020 IBRD-91240 Fee Charges 22,860.28
Oct 7, 2020 IBRD-91240 Loan Disb 1,877,351.50
May 15, 2020 IBRD-91240 Loan Commitment 9,000,000.00
Oct 15, 2021 IBRD-93040 Loan Commitment 12,000,000.00
Apr 24, 2024 IBRD-91240 Loan Disb 1,982.30
Apr 24, 2024 IBRD-91240 Loan Disb -1,982.30
Apr 24, 2024 IBRD-91240 Loan Disb -36,123.73
Apr 24, 2024 IBRD-91240 Loan Disb 36,123.73
Apr 24, 2024 IBRD-91240 Loan Disb -38,106.02
Jul 5, 2024 IBRD-91240 Int Charges 10,095.14
Jul 5, 2024 IBRD-91240 Loan Repay 7.58
Jul 5, 2024 IBRD-91240 Int Charges 111.37
Jul 5, 2024 IBRD-91240 Int Charges 129.37
Jul 5, 2024 IBRD-91240 Loan Repay 25,207.58
Jul 5, 2024 IBRD-91240 Loan Repay 28,832.07
Jul 5, 2024 IBRD-91240 Loan Repay 26,472.87
Jul 5, 2024 IBRD-91240 Loan Repay 167.24
Jul 5, 2024 IBRD-91240 Int Charges 895.16
Jul 5, 2024 IBRD-91240 Int Charges 1,049.09
Jul 5, 2024 IBRD-91240 Int Charges 3,618.54
Jul 5, 2024 IBRD-91240 Int Charges 37.61
Jul 5, 2024 IBRD-91240 Loan Repay 554,438.60
Jul 5, 2024 IBRD-91240 Int Charges 11.47
Jul 5, 2024 IBRD-91240 Int Charges 13.44
Jul 5, 2024 IBRD-91240 Int Charges 46.37
Jul 5, 2024 IBRD-91240 Int Charges 0.49
Dec 15, 2023 IBRD-91240 Loan Repay 161.78
Dec 15, 2023 IBRD-91240 Int Charges 976.81
Dec 15, 2023 IBRD-91240 Int Charges 114.33
Dec 15, 2023 IBRD-91240 Int Charges 7.68
Dec 15, 2023 IBRD-91240 Int Charges 11,015.95
Dec 15, 2023 IBRD-91240 Int Charges 1,144.77
Dec 15, 2023 IBRD-91240 Int Charges 3,948.58
Dec 15, 2023 IBRD-91240 Int Charges 41.07
Dec 15, 2023 IBRD-91240 Loan Repay 561,814.06
Dec 15, 2023 IBRD-91240 Loan Repay 25,542.91
Dec 15, 2023 IBRD-91240 Loan Repay 26,825.03
Dec 15, 2023 IBRD-91240 Loan Repay 29,215.61
May 24, 2023 IBRD-91240 Int Charges 110.24
May 24, 2023 IBRD-91240 Int Charges 10,798.02
May 24, 2023 IBRD-91240 Int Charges 957.49
May 24, 2023 IBRD-91240 Int Charges 1,122.12

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Procurement Satisfactory 2023-10-31
Progress towards achievement of PDO Satisfactory 2023-10-31
Project Management Satisfactory 2023-10-31
Financial Management Satisfactory 2023-10-31
Monitoring and Evaluation Satisfactory 2023-10-31
Overall Implementation Progress (IP) Satisfactory 2023-10-31

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents.Value2.0023.005.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Percentage of suspected cases of COVID-19 reported and investigated per approved protocol (Percentage)Value0.0060.0060.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Percentage of diagnosed cases treated per approved protocol (Percentage)Value0.00100.0070.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population targets defined in the national planValue2.002.0060.00
    DateJune 30, 2021June 30, 2021June 30, 2024
    Comment
  • Percentage of women vaccinated, which are included in the priority population targets defined in the national planValue0.600.6050.00
    DateJune 30, 2021June 30, 2021June 28, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of targeted sites where requested Cold Chain Equipment has been installed and functionalValue0.000.00100.00
    DateJune 30, 2021June 30, 2021June 30, 2024
    Comment
  • Radio/TV Stations broadcast COVID-19 vaccine communication message in French and local languagesValueNoNoYes
    DateJune 30, 2021August 13, 2021June 30, 2024
    Comment
  • Gender sensitive educational communication materials on COVID-19 vaccines distributedValueNoNoYes
    DateJune 30, 2021August 13, 2021June 30, 2024
    Comment
  • Share of female community health workers provided with vaccine informationValue0.000.0040.00
    DateJune 30, 2021August 31, 2021June 28, 2024
    Comment
  • Share of vaccinators who are femaleValue0.000.0030.00
    DateJune 30, 2021June 30, 2021June 28, 2024
    Comment
  • Percentage of health staff equipped with appropriate PPE for infection prevention and control per MOH-approved protocols (Percentage). (Percentage)Value50.0095.0080.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Number of suspected COVID19 cases tested per MOH-approved protocols at the 5 designated laboratories equipped to conduct COVID-19 diagnosis (number). (Number)Value572.0070000.0060000.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • M&E system established to monitor COVID-19 preparedness and response plan (Yes/No)ValueNoYesYes
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Number of WB financed designated ambulances to transport COVID19 patients per MOH-approved protocols (number) (Number)Value0.0026.0010.00
    DateApril 7, 2020September 14, 2023June 30, 2022
    Comment
  • Percentage of grievances received that were timely addressed through the GRM mechanism (Percentage)Value0.000.0070.00
    DateJune 30, 2021August 13, 2021June 30, 2024
    Comment
  • Number of Effective Vaccine Management (EVM) assessments completed with composite scores of 80% or higherValue0.000.005.00
    DateJune 30, 2021June 30, 2021June 30, 2024
    Comment
  • Number of health departments with health facilities that have adopted COVID-19 related AEFI mechanismsValue14.0014.0047.00
    DateJune 30, 2021June 30, 2021June 30, 2024
    Comment
  • Number of vaccination centers that have implemented standard operating procedures (SOPs) or guidelines updated for collection and disposal of COVID-19 vaccine related medical wasteValue24.0024.0057.00
    DateJune 30, 2021June 30, 2021June 30, 2024
    Comment